Selena Maranjian has positions in Bristol Myers Squibb, Pfizer, Schwab U.S. Dividend Equity ETF, and Western Union. The ...

Pfizer's (NYSE:PFE) stock is up by 4.7% over the past three months. Given that the markets usually pay for the long-term ...

Pfizer is one of the world's largest pharmaceutical companies. Even after losing more than half of its value, it still has a ...

Pfizer has taken a beating in recent years, and its market cap is now around $140 billion. But with the company still ...

Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. With 66% stake, ...

The agreement allows Pfizer to utilize Novavax’s Matrix-M adjuvant in up to two disease areas with its products. Under the ...

Shares of US biotech Novavax were up 9% at $8.72 by midday on Tuesday, after it revealed it has entered into a license ...

Pfizer Inc. (NYSE: PFE) is included among the 13 Best Dividend Stocks Paying Over 6%.

While Pfizer Inc's (NYSE:PFE) revenue trends remained uneven in the third quarter, the company exhibited "continued cost discipline," according to Goldman Sachs. The Pfizer Analyst: Analyst Asad ...

TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer today and set a price target of $30.00. According to TipRanks, Scala is a 4-star analyst with an average return of 11.3% and a 64.82% ...

Novavax shares are trading higher Tuesday after the company announced it entered into a license agreement with Pfizer for ...

The 11.7% economic interest in specialist HIV company ViiV Healthcare that is currently held by US pharma giant Pfizer is to ...